Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS SUMMARY: Doubts Raised Over AstraZeneca Virus Jab

Mon, 08th Feb 2021 11:05

(Alliance News) - The following is a summary of top news stories Monday.

----------

COMPANIES

----------

Britons face needing a third jab this year amid concerns about the Oxford University and AstraZeneca vaccine's effectiveness against the South African coronavirus variant. UK Vaccines Minister Nadhim Zahawi was forced to defend the vaccine after a new study in South Africa found it was not effective at preventing mild illness caused by the more infectious mutation. South Africa has suspended the rollout of the British-designed vaccine to healthcare staff following the results, which have yet to be peer reviewed. Zahawi urged the public to keep faith with the Oxford jab as scientists working on the vaccine raised the prospect of having a booster dose available by the autumn. The number of people in the UK who have received a first dose of a vaccine passed the 12 million mark, with jabs administered at a rate of almost 1,000 per minute during a one-hour period over the weekend.

----------

Experian said it is still investigating after recent media reports in Brazil suggested data being sold illegally online might have been sourced from its Serasa business. The London-based credit-checking firm noted "recent media reports" that data, potentially sourced from its Brazilian Serasa unit's non-sensitive marketing data, is being illegally offered for sale online. Experian said it is carrying out a "detailed forensic investigation" into these reports. So far, Experian said it has ascertained that the data for sale "includes photographs, social security INSS, vehicle registrations and social media login details" which its Serasa unit does not hold or collect. Moreover, it said it has seen no evidence of positive or negative credit data being illegally obtained from Serasa, and its "exhaustive investigations" have so far turned up no evidence that its technology systems were compromised.

----------

Arrow Global responded to TDR Capital's fourth potential takeover bid, this time accepted by the financial firm's founder and chief investment officer. TDR, a private equity firm, is offering 305 pence per share in cash, up from its most recent 290p per share offer, which had been rejected by Arrow's board back in January. "The board of Arrow Global is considering the proposal and a further announcement will be made in due course," the company said. The new 305p per share offer is an approximately 67% premium to Arrow's 182.3p average share price for the three months ended Thursday last week, TDR noted, and a 36% premium to its closing price of 224.0p on Thursday. Arrow Global shares added 3.8% on Friday to close at 231.50p and were up 26% at 290.50p each on Monday morning, valuing the company at around GBP515 million.

----------

boohoo Group said it has agreed to buy the Dorothy Perkins, Wallis and Burton brands out of administration for GBP25.2 million. The online-only fashion retailer will be buying the e-commerce and digital assets and associated intellectual property rights, including customer data, related business information and inventory of the Burton, Dorothy Perkins and Wallis brands. The deal does not include any stores. The brands are part of Philip Green's Arcadia Group Ltd, which went under back in November, putting 13,000 jobs at risk. Arcadia's crown jewel, Topshop, was snapped up - along with Topman, Miss Selfridge and HIIT - by ASOS last week.

----------

Drax Group announced its Canadian subsidiary has signed an agreement to acquire Canadian biomass producer and supplier Pinnacle Renewable Energy. The electrical power station operator said deal values Pinnacle's fully diluted equity at CAD385 million, or GBP226 million, with an implied enterprise value of CAD741 million, including net debt of CAD356 million. The acquisition - which is subject to Drax and Pinnacle shareholder, court and regulatory approvals, and the satisfaction of other conditions - has been unanimously recommended by the board of Pinnacle.

----------

MARKETS

----------

Investors in Europe put aside concerns around the Oxford-AstraZeneca vaccine, with investors instead drawing on optimism over a US stimulus package, IG Markets Senior Market Analyst Joshua Mahony noted. US stock market futures were pointing higher, with the S&P 500 called up 0.2% and the Nasdaq Composite up 0.3%. The two benchmarks are set to build on Friday's record close. The Dow Jones Industrial Average is called up 0.3%.

----------

FTSE 100: up 0.8% at 6,538.40

FTSE 250: down 0.1% at 21,043.36

AIM ALL-SHARE: down 0.2% at 1,209.54

GBP: weaker at USD1.3696 (USD1.3728)

EUR: up at USD1.2033 (USD1.2025)

GOLD: higher at USD1,815.13 per ounce (USD1,808.40)

OIL (Brent): higher at USD60.04 a barrel (USD59.62)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

US President Joe Biden anticipates the US rivalry with China will take the form of "extreme competition" rather than conflict between the two world powers. Biden said in an excerpt of a CBS interview aired Sunday that he has not spoken with Chinese counterpart Xi Jinping since he became US president. "He's very tough. He doesn't have – and I don't mean it as a criticism, just the reality – he doesn't have a democratic, small D, bone in his body," Biden said. "I've said to him all along, that we need not have a conflict. But there's going to be extreme competition," Biden said. "I'm not going to do it the way Trump did. We're going to focus on international rules of the road." China is considered in Washington as the US's number one strategic adversary, and the primary challenge on the world stage.

----------

Amazon.com and other internet retail giants could be hit with an online sales tax in a move designed to claw back money the UK owes after heavy borrowing during the pandemic. Treasury sources confirmed Chancellor Rishi Sunak is considering targeting companies that have done well out of the pandemic in order to pay back UK government debts incurred while supporting industries through the coronavirus crisis. The move is being considered as part of a review into business rates following a consultation last year. The Sunday Times reported that leaked emails showed Treasury officials had summoned tech firms and retailers to a meeting this month to discuss how an online sales tax could work.

----------

Irish Foreign Minister Simon Coveney said on Sunday he would be open to an extension of post-Brexit transition period rules for Northern Ireland, the subject of crisis talks between London and Brussels. Coveney told RTE Radio he was "open to advocating for modest extensions of grace periods" but said that scrapping the Northern Ireland Protocol on the movement of goods was out of the question. The Northern Ireland Protocol keeps goods flowing between EU state the Republic of Ireland and Northern Ireland, a part of the UK. The aim is to avoid the creation of a hard border, which could lead to a flare-up in old conflicts. The EU drew international anger last month when it proposed to trigger an emergency clause in the protocol to make controls at the Irish border possible when implementing its new vaccine export register. Following backlash from Dublin, Belfast and London, the EU swiftly backtracked.

----------

Germany's industrial production data painted a mixed picture, with output lagging market estimates monthly in December, but numbers showed a a more moderate year-on-year decline. According to Destatis, industrial production fell 1.0% annually in December, following a 2.5% slide in November. Monthly, output was unchanged, though 0.3% growth was expected, according to market estimates cited by FXStreet. In November, industrial production rose 1.5%. On a calendar-adjusted basis, output in the whole of 2020 was 8.5% lower.

----------

European Central Bank Chief Christine Lagarde on Sunday rejected calls to cancel debts run up by eurozone members to buttress their economies during the Covid-19 crisis. The ECB has taken unprecedented steps to cushion the economic blow from the pandemic in the 19-nation euro area, launching a massive bond-buying scheme that has so far totalled EUR1.85 trillion. "Cancelling that debt is unthinkable," Lagarde told France's Le Journal du Dimanche weekly. "It would be a violation of the European treaty which strictly forbids monetary financing of states," she said, calling it one of the "founding pillars" of the euro single currency. She was reacting to a call on Friday by more than 100 economists for the ECB to further boost the economic recovery of eurozone members by forgiving their debts.

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.